Literature DB >> 19161109

Urologic diseases in the Islamic Republic of Iran: what are the public health priorities?

A Basiri1, S M Mousavi, M Naghavi, I A Araghi, S A Namini.   

Abstract

This study was designed to estimate the burden of urologic diseases in the Islamic Republic of Iran as a practical method for defining public health priorities. Using World Health Organization guidelines for national burden of disease studies, 6 steps were performed: selecting diseases to include; dynamic modelling of diseases; gathering data about urologic diseases; computing the local disability weights of urologic diseases; data analysis with DisMod II; and computing the disability-adjusted life years for each disease. Renal calculus, acute cystitis, chronic prostatitis, benign prostate hyperplasia, male infertility and adult polycystic kidney disease comprised the greatest burden.

Entities:  

Mesh:

Year:  2008        PMID: 19161109

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  4 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

Review 2.  Review of disability weight studies: comparison of methodological choices and values.

Authors:  Juanita A Haagsma; Suzanne Polinder; Alessandro Cassini; Edoardo Colzani; Arie H Havelaar
Journal:  Popul Health Metr       Date:  2014-08-23

3.  Effects of COVID-19 pandemics on urinary metabolites in kidney stone patients: our kidney stone prevention clinic experience.

Authors:  Sanaz Tavasoli; Nasrin Borumandnia; Abbas Basiri; Maryam Taheri
Journal:  Environ Health Prev Med       Date:  2021-12-02       Impact factor: 3.674

Review 4.  A systematic literature review of disability weights measurement studies: evolution of methodological choices.

Authors:  Periklis Charalampous; Suzanne Polinder; Jördis Wothge; Elena von der Lippe; Juanita A Haagsma
Journal:  Arch Public Health       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.